E-LIB Suche - Ergebnisse für: Yu Sunakawa

1

The Molecular Landscape of Gastric Cancers for Novel Target..:

Yamamoto, Hiroyuki ; Arai, Hiroyuki ; Oikawa, Ritsuko...
Targeted Oncology. 19 (2024) 3 - p. 459-471 , 2024

Link: https://doi.org/10.1007/..

2

Plasma Angiogenic Factors as Predictors of the Efficacy of ..:

Yuki, Satoshi ; Yamazaki, Kentaro ; Sunakawa, Yu...
Clinical Colorectal Cancer. 23 (2024) 2 - p. 147-159.e7 , 2024

Link: https://doi.org/10.1016/..

3

An approach for improvement of the accuracy of cancer gene ..:

Imoto, Kiyomi ; Yamamoto, Hiroyuki ; Ohkawa, Chie...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 571-581 , 2024

Link: https://doi.org/10.1007/..

4

Microsatellite instability: A 2024 update:

Yamamoto, Hiroyuki ; Watanabe, Yoshiyuki ; Arai, Hiroyuki...
Cancer Science. 115 (2024) 6 - p. 1738-1748 , 2024

Link: https://doi.org/10.1111/..

5

Real-World Evidence of FOLFIRI Combined with Anti-Angiogene..:

Kagawa, Yoshinori ; Wang, Chaochen ; Piao, Yongzhe...
Targeted Oncology. , 2024

Link: https://doi.org/10.1007/..

6

Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevac..:

Arai, Hiroyuki ; Tsuda, Takashi ; Sunakawa, Yu...
Cancer Medicine. 13 (2024) 7 - p. , 2024

Link: https://doi.org/10.1002/..

7

Second-line tislelizumab versus chemotherapy in Japanese pa..:

Hara, Hiroki ; Satoh, Taroh ; Kojima, Takashi...
Esophagus. 21 (2024) 2 - p. 102-110 , 2024

Link: https://doi.org/10.1007/..

8

Exploratory Biomarker Analysis Using Plasma Angiogenesis-Re..:

Sunakawa, Yu ; Kuboki, Yasutoshi ; Watanabe, Jun...
Targeted Oncology. 19 (2024) 1 - p. 59-69 , 2024

Link: https://doi.org/10.1007/..

9

Correction: Addition of docetaxel to S-1 results in signifi..:

Kodera, Yasuhiro ; Yoshida, Kazuhiro ; Kochi, Mitsugu...
Gastric Cancer. , 2024

Link: https://doi.org/10.1007/..

10

Clinical and Diagnostic Utility of Genomic Profiling for Di..:

Ishikawa, Marin ; Nakamura, Kohei ; Kawano, Ryutaro...
Cancers. 16 (2024) 8 - p. 1504 , 2024

Link: https://doi.org/10.3390/..

11

Tumor Response Predicts Survival Time of Nivolumab Monother..:

Sunakawa, Yu ; Sakamoto, Yasuhiro ; Kawabata, Ryohei...
The Oncologist. , 2024

Link: https://doi.org/10.1093/..

12

A Multicenter, Phase II Trial of Schedule Modification for ..:

Kawabata, Ryohei ; Izawa, Naoki ; Suzuki, Takahisa...
Targeted Oncology. 18 (2023) 3 - p. 359-368 , 2023

Link: https://doi.org/10.1007/..

13

A Phase II Trial of Trifluridine/Tipiracil in Combination w..:

Izawa, Naoki ; Masuishi, Toshiki ; Takahashi, Naoki...
Targeted Oncology. 18 (2023) 3 - p. 369-381 , 2023

Link: https://doi.org/10.1007/..

14

Validity and utility of blood tumor mutational burden (bTMB..:

Mishima, Saori ; Nakamura, Yoshiaki ; Tukachinsky, Hanna...
The Journal of Liquid Biopsy. 1 (2023) - p. 100003 , 2023

Link: https://doi.org/10.1016/..

15

Clinical significance of circulating-tumour DNA analysis by..:

Umemoto, Kumiko ; Sunakawa, Yu ; Ueno, Makoto...
British Journal of Cancer. 128 (2023) 8 - p. 1603-1608 , 2023

Link: https://doi.org/10.1038/..